InvestorNewsBreaks – RIV Capital Inc. (TSX: RIV) (OTC: CNPOF) Announces Court Approval of PharmHouse Asset Purchase Agreement, $25M Voluntary Payment

March 12, 2021 09:50:27
RIV Capital (TSX: RIV) (OTC: CNPOF), (formerly Canopy Rivers Inc.), today announced that the asset purchase agreement proposed by PharmHouse Inc. has been approved by the Ontario Superior Court. The agreement outlines PharmHouse’s intent to sell various operating assets, including its facility and certain equipment located at the facility. As part of the announcement, RIV Capital also noted that it will make a voluntary $25 million payment to the lenders of PharmHouse’s nonrevolving syndicated Credit Facility, thereby reducing the company’s estimated liability in respect to the PharmHouse Credit facility by that same amount. RIV Capital noted that it is making the payment prior to the due date of March 31, 2021, with the intent, in part, to reduce near-term debt servicing costs and for tax-planning purposes in relation to the company’s recent disposition of certain assets to Canopy Growth Corporation, which resulted in a significant capital gain for the company. PharmHouse’s asset purchase agreement received court approval pursuant to a court order granted in PharmHouse’s proceedings under the Companies’ Creditors Arrangement Act. The agreement is still subject to certain closing conditions, which the company is confident will be satisfied during the next fiscal quarter. In addition, the company noted that court-ordered stay of proceedings with respect to PharmHouse was also extended to June 30, 2021 . To view the full press release, visit About RIV Capital Inc. RIV Capital is an investment and acquisition company specializing in cannabis with a portfolio of 13 companies across various segments of the cannabis value chain. The company believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging its industry insights, in-house expertise and thesis-driven approach to investing, RIV Campital aim to provide shareholders with exposure to specialized and disruptive cannabis companies. For more information about the company, visit NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork.